The perils of clinical trials: confidentiality and infringement

A variety of IP issues arise when conducting clinical trials, including confidentiality and potential liability for patent infringement. Two recent developments in this area, the UK’s expansion of the Bolar exemption to patent infringement and the case of AGA Medical Corp. v Occlutech (UK) Ltd, highlight the concerns in this area and the difficulties of ensuring harmonisation of the patent system throughout Europe.